Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel allergen challenge proof-of-concept trial in asthma
2012-003698-25Phase 4Unknown
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of clopidogrel in asthma and allergic asthma, sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Change in sputum eosinophil count after allergen challenge. Status: unknown.
02
Drugs
clopidogrel
03
Conditions
asthmaallergic asthma
Beyond the preview
Go deeper on 2012-003698-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003698-25.